Person: KEPENEKLİ KADAYİFCİ, EDA
Loading...
Email Address
Birth Date
Research Projects
Organizational Units
Job Title
Last Name
KEPENEKLİ KADAYİFCİ
First Name
EDA
Name
3 results
Search Results
Now showing 1 - 3 of 3
Publication Metadata only Kronik granülomatöz hastalıklı olgularda küf ilişkili invaziv enfeksiyonlar: Tek merkez deneyimi(2022-03-17) AYDINER, ELİF; KEPENEKLİ KADAYİFCİ, EDA; ÖZEN, AHMET OĞUZHAN; BARIŞ, SAFA; Ergenç Z., Bilgiç Ertan S., Barış S., Aydıner E., Özen A. O., Aslan S., Yılmaz S., Parlak B., Kepenekli Kadayifci E.Publication Metadata only Invasive mold infections in chronic granulomatous disease: a single-center retrospective cohort(2022-05-09) AYDINER, ELİF; BARIŞ, SAFA; ÖZEN, AHMET OĞUZHAN; KEPENEKLİ KADAYİFCİ, EDA; Ergenç Z., Eltan S., Aydıner E., Barış S., Özen A. O. , Aslan S., Yılmaz S., Parlak B., Kepenekli Kadayifci E.Publication Open Access Single-center experience in vaccination of children in special risk groups: A multidisciplinary institutional consensus protocol(2023-09-01) BARIŞ, HATİCE EZGİ; KEPENEKLİ KADAYİFCİ, EDA; ÜTÜK, BURAK; ŞAHİN, PINAR; TOKUÇ, AYŞE GÜLNUR; KOÇ, AHMET; AYDINER, ELİF; BORAN, PERRAN; BARIŞ H. E., Kepenekli E., Sakar F. İ. A., ÜTÜK B., ŞAHİN P., Ergenç Z., TOKUÇ A. G., KOÇ A., Karakoç-Aydıner E., BORAN P.Objective: Despite marked improvements in the accessibility of childhood vaccines, knowledge gaps remain about the vaccination of children in special risk groups (SRG). This study aimed to analyze the clinical data of children vaccinated in SRG in a single-center unit to contribute to the clinical evidence for the specific planning of immunization of children in SRG. The secondary aim is to present institutional consensus on the vaccination of children in SRG. Materials and Methods: This retrospective study was conducted at a single-center pediatric vaccination clinic. Patient charts between 2018 and 2021 were retrospectively reviewed, and clinical and laboratory data were extracted. Serial joint meetings with multiple healthcare pro-fessionals were performed to develop an institutional protocol for vaccination. Results: There were 479 children vaccinated between 2018 and 2021 for reasons such as post-chemotherapy, after hematopoietic stem cell transplantation, before/after solid organ trans-plantation, allergies, and chronic diseases. Of these, 298 (62.2%) children vaccinated in the unit due to a history of food or vaccine allergies were excluded. One hundred eighty-one children were vaccinated at a median age of 11 [7-15] years. Most children were vaccinated after treatment for malignancies. Solid tumors were the most frequent malignancy (67%), followed by acute lymphoblastic leukemia (29.0%) and acute myeloid leukemia (4.0%). Institutional vaccination protocols for cancer survivors, hematopoietic stem cells, and solid organ recipient children were developed and presented. Conclusion: There is a need to prepare national guidelines for vaccinating children with altered immunocompetence. Sharing vaccination practices by multidisciplinary vaccination units might increase and provide knowledge to develop national policies.